Pimavanserin
ACP-103-033
Phase 2 small_molecule completed
Quick answer
Pimavanserin for Agitation and Aggression in Alzheimer's Disease is a Phase 2 program (small_molecule) at ACADIA PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ACADIA PHARMACEUTICALS INC
- Indication
- Agitation and Aggression in Alzheimer's Disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed